[1]
SRIKANTH et al. 2019. DESIGN AND OPTIMIZATION OF DOXORUBICIN HCL PRONIOSOMES BY-DESIGN OF EXPERIMENT. International Journal of Pharmacy and Pharmaceutical Sciences. 11, 7 (Jul. 2019), 90–95. DOI:https://doi.org/10.22159/ijpps.2019v11i7.33798.